<div id="readability-page-1"><div><div>NVIDIA Corp NVDA is deepening its roots in the healthcare sector, on Thursday announcing new partnerships aimed at revolutionizing drug discovery and development.What To Know: CEO Jensen Huang earlier revealed collaborations with weight-loss drug maker Novo Nordisk and life sciences firm IQVIA. The partnerships will leverage NVIDIA's BioNeMo, Omniverse and other AI platforms to create advanced models and “orchestrator agents” that accelerate complex research and clinical workflows, reducing timelines from weeks to days.This move is part of a broader strategy highlighted at GTC Paris, where the company emphasized its push into sovereign AI and robotics. Analysts from JPMorgan reiterated an Overweight rating, citing the massive opportunity in sovereign nations building out their own AI infrastructure, an incremental market on top of existing cloud demand.Read Also: What’s Going On With Adobe Stock Thursday?Huang also commented on the competitive landscape, noting that while Nvidia is a generation ahead, continued U.S. restrictions could bolster competitors like Huawei in China. He identified robotics and autonomous vehicles as the defining industries for the coming decade.NVDA Price Action: According to data from Benzinga Pro, Thursday’s strategic announcements are being cheered by investors. Shares of Nvidia closed Thursday afternoon at $145 a share, a gain of 1.52%. The stock has shown strong momentum over the past month, rising 17.80%.Read Also: Short Seller Says AppLovin Is ‘Desperate And Doomed,’ Shares SlideBy now, you're likely curious about how to participate in the market for NVIDIA, be it to purchase shares or even attempt to bet against the company.Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.In the case of NVIDIA, which is trading at $144.78 as of writing the article, $100 would buy you 0.69 shares of stock.If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit off of the share price decline.According to data from Benzinga Pro, NVDA has a 52-week high of $153.13 and a 52-week low of $86.63.</div></div></div>

NVIDIA Corp is expanding into the healthcare sector with new partnerships aimed at enhancing drug discovery. CEO Jensen Huang announced collaborations with Novo Nordisk and IQVIA, utilizing NVIDIA's AI platforms to streamline research processes. Analysts from JPMorgan maintain an Overweight rating, highlighting opportunities in sovereign AI infrastructure. Following these announcements, NVIDIA's stock rose 1.52% to $145, marking a 17.80% increase over the past month. The stock's 52-week range is $86.63 to $153.13.

- NVIDIA Corp is expanding into the healthcare sector with new partnerships aimed at enhancing drug discovery and development.  
- Collaborations with Novo Nordisk and IQVIA will utilize NVIDIA's AI platforms to streamline research processes, significantly reducing timelines.  
- Analysts see potential in NVIDIA's strategy, with shares rising 1.52% to $145, reflecting strong investor interest amid a broader push into AI and robotics.

NVIDIA Stock Is Rising Thursday: What's Going On?